Cargando…

m(6)A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis

N(6)-methyladenosine (m(6)A) is the most common RNA modification in eukaryotic RNAs. Although the important roles of m(6)A in RNA fate have been revealed, the potential contribution of m(6)A to RNA function in various diseases, including hepatocellular carcinoma (HCC), is still unclear. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Huamei, Yang, Jinhun, Lu, Rongzhou, Huang, Yanyan, Huang, Zheng, Huang, Lizheng, Zeng, Min, Wei, Yunyu, Xu, Zuoming, Li, Wenchuan, Pu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625930/ https://www.ncbi.nlm.nih.gov/pubmed/37926706 http://dx.doi.org/10.1038/s41598-023-45449-w

Ejemplares similares

m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway
por: Zhang, Zhen, et al.
Publicado: (2023)

N(6)-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling
por: Wei, Huamei, et al.
Publicado: (2023)

IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism
por: Pu, Jian, et al.
Publicado: (2020)

Hypoxia-induced Fascin-1 upregulation is regulated by Akt/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and Hippo/YAP activation
por: Pu, Jian, et al.
Publicado: (2021)

Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling
por: Wei, Huamei, et al.
Publicado: (2022)

N(6)-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC
por: Tan, Chuan, et al.
Publicado: (2023)

M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway
por: Pu, Jian, et al.
Publicado: (2021)

ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis
por: Pu, Jian, et al.
Publicado: (2021)

LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
por: Wei, Qing, et al.
Publicado: (2023)

Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages
por: Pu, Jian, et al.
Publicado: (2021)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
por: Wei, Huamei, et al.
Publicado: (2021)

IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R
por: Qiao, Chenyang, et al.
Publicado: (2021)

HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way
por: Wu, Xianjian, et al.
Publicado: (2023)

Corrigendum: Hepatoma Cell-Derived Extracellular Vesicles Promote Liver Cancer Metastasis by Inducing the Differentiation of Bone Marrow Stem Cells Through microRNA-181d-5p and the FAK/Src Pathway
por: Wei, Huamei, et al.
Publicado: (2021)

Hepatoma Cell-Derived Extracellular Vesicles Promote Liver Cancer Metastasis by Inducing the Differentiation of Bone Marrow Stem Cells Through microRNA-181d-5p and the FAK/Src Pathway
por: Wei, Huamei, et al.
Publicado: (2021)

Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1
por: Huang, Chaoqing, et al.
Publicado: (2022)

IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
por: Huang, Wei, et al.
Publicado: (2023)

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer
por: Wan, Weijun, et al.
Publicado: (2022)

RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m(6)A modification
por: Zhao, Yahui, et al.
Publicado: (2023)

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer
por: Huang, Xinwei, et al.
Publicado: (2018)

MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification
por: Shi, Wenjing, et al.
Publicado: (2022)

Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion
por: Peng, Wenbei, et al.
Publicado: (2023)

CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA–protein ternary complex
por: Ma, Qiang, et al.
Publicado: (2022)

m(6)A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma
por: Wu, Hansheng, et al.
Publicado: (2022)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
por: Glaß, Markus, et al.
Publicado: (2021)

IGF2BP2 Regulates MALAT1 by Serving as an N6-Methyladenosine Reader to Promote NSCLC Proliferation
por: Han, Le, et al.
Publicado: (2022)

A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1
por: Huang, Qi, et al.
Publicado: (2020)

Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway
por: Mao, Yan, et al.
Publicado: (2023)

METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification
por: Guo, Zhenyun, et al.
Publicado: (2022)

Oncofetal protein IGF2BP1 regulates IQGAP3 expression to maintain stem cell potential in cancer
por: Myint, Khine, et al.
Publicado: (2022)

IGF2BP1: A post-transcriptional “driver” of tumor cell migration
por: Stöhr, Nadine, et al.
Publicado: (2012)

IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
por: Haase, Jacob, et al.
Publicado: (2020)

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
por: Xi, Yufeng, et al.
Publicado: (2022)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

m(6)A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
por: Lang, Chuandong, et al.
Publicado: (2021)

RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner
por: Cai, Xianlei, et al.
Publicado: (2021)

HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification
por: Wang, Jiayu, et al.
Publicado: (2023)

53BP1-ACLY-SLBP-coordinated activation of replication-dependent histone biogenesis maintains genomic integrity
por: Wu, TingTing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kiiudo8u559g0d0sa9an8l0lmo